C. Vézina

发表

A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third‐generation B‐domain‐deleted recombinant factor VIII

E. Dubé, A. Bonnefoy, C. Merlen, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Incidence and risk factors for inhibitor development in previously untreated severe haemophilia A patients born between 2005 and 2010

M. Carcao, C. Infante-Rivard, D. Lillicrap, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Psychosexual Impacts of Human Papillomavirus As a first-line resource, physicians have a crucial responsibility to provide HPV patients with counselling suited to their needs. This requires physicians to go beyond their traditional roles and adopt fuller, more personalized coun-

C. Vézina, M. Steben, 2001 .

Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study

N. André, O. Hrusak, M. Devidas, 2021, The Lancet Oncology.

Acquired thrombotic thrombocytopenic purpura with isolated CFHR3/1 deletion—rapid remission following complement blockade

A. Bonnefoy, C. Vézina, G. Rivard, 2018, Pediatric Nephrology.

Clinical characteristics and outcomes of SARS‐CoV‐2 infection in pediatric oncology patients in the province of Quebec

C. Vézina, J. Brossard, T. Tran, 2022, Pediatric blood & cancer.

Alloantibody developed in a factor XIII A subunit deficient patient during substitution therapy; characterization of the antibody

C. Vézina, G. Rivard, É. Katona, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

A prospective surveillance study in haemophilia B patients following a population switch to recombinant factor IX (nonacog gamma)

J. Gauthier, A. Bonnefoy, C. Merlen, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Evaluation of anti‐factor VIII antibodies in haemophilia A subjects switching products following a provincial tender

A. Bonnefoy, C. Merlen, Jean-François Castilloux, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Labor strategies and agribusiness counterstrike during the Bracero Era: the peculiar case of the National Farm Labor Union, 1946–1952

C. Vézina, 2016 .

Genetic Aberrations Leading to MAPK Pathway Activation Mediate Oncogene-Induced Senescence in Sporadic Pilocytic Astrocytomas

S. Pfister, C. Hawkins, H. Witt, 2011, Clinical Cancer Research.

Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial.

B. Geoerger, A. Pappo, A. Petrilli, 2019, The Lancet. Oncology.

Pilocytic Astrocytomas Mediate Oncogene-Induced Senescence in Sporadic Genetic Aberrations Leading to MAPK Pathway Activation

David T. W. Jones, S. Pfister, C. Hawkins, 2012 .

Novel 3q27.2‐qter deletion in a patient with Diamond–Blackfan anemia and immunodeficiency: Case report and review of literature

G. Stewart, N. Braverman, R. Alizadehfar, 2017, American journal of medical genetics. Part A.

Deciphering a novel complex inversion affecting F8 in a family with severe haemophilia A by optical genome mapping

J. Ragoussis, A. Montpetit, C. Carvalho, 2023, Haemophilia : the official journal of the World Federation of Hemophilia.

Phase 1/2 KEYNOTE-051 study of pembrolizumab (pembro) in pediatric patients (pts) with advanced melanoma or a PD-L1+ advanced, relapsed, or refractory solid tumor or lymphoma.

B. Geoerger, A. Pappo, A. Petrilli, 2017 .

Procedural Pediatric Sedation by Nurses: Available, Competent, and Safe

C. Cyr, C. Vézina, E. Paul-Savoie, 2012, International journal of pediatrics.

Challenges in diagnosis of von Willebrand disease in the presence of combined mutations of different genes

J. Gauthier, D. Lillicrap, A. Bonnefoy, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Acquired thrombotic thrombocytopenic purpura with isolated CFHR3/1 deletion—rapid remission following complement blockade

A. Bonnefoy, C. Vézina, G. Rivard, 2018, Pediatric Nephrology.